Astria Therapeutics, Inc. ( ATXS) - Stock Earnings

ATXS Quarterly earnings

DateEarningsRevenue
2025Q1 -33.7 million USD — USD
2025Q2 -33.1 million USD — USD
2025Q3 -31.6 million USD 706000 USD

ATXS Yearly earnings

DateEarningsRevenue
2022 -50.2 million USD 0 USD
2023 -72.9 million USD — USD
2024 -94.3 million USD — USD

ATXS

Price: $12.58

52 week price:
3.56
13.29

Earnings Per Share: -2.14 USD

P/E Ratio: -5.99

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 121600

Market Capitalization: 731.8 million

Links: